Featured Research

from universities, journals, and other organizations

Stress takes its toll in Parkinson's disease

Date:

November 11, 2010

Source:

Northwestern University

Summary:

A stressful lifestyle could lead to the premature death of a group of neurons, whose loss triggers the symptoms of Parkinson's disease, according to a new study. Isradipine, a drug already approved for human use by the FDA, has been shown in preclinical studies to reduce the stress on these neurons and rejuvenate them. Scientists currently are conducting a clinical trial to find out if isradipine can be used safely and is tolerated by patients with Parkinson's.

Related Articles

The same appears to be true of neurons in the brain. According to a new Northwestern Medicine study published Nov. 10 in the journal Nature, dopamine-releasing neurons in a region of the brain called the substantia nigra lead a lifestyle that requires lots of energy, creating stress that could lead to the neurons' premature death. Their death causes Parkinson's disease.

"Why this small group of neurons dies in Parkinson's disease is the core question we struggled with," says lead author D. James Surmeier, the Nathan Smith Davis Professor and chair of physiology at Northwestern University Feinberg School of Medicine. "Our research provides a potential answer by showing this small group of neurons uses a metabolically expensive strategy to do its job. This 'lifestyle' choice stresses the neurons' mitochondria and elevates the production of superoxide and free radicals -- molecules closely linked to aging, cellular dysfunction and death."

The good news is preclinical research shows this stress can be controlled with a drug already approved for human use. By preventing calcium entry, the drug isradipine reduced the mitochondrial stress in dopamine-releasing neurons to the levels seen in neurons not affected by the disease.

Northwestern Medicine scientists currently are conducting a clinical trial to find out if isradipine can be used safely and is tolerated by patients with Parkinson's. Isradipine is already approved by the Food and Drug Administration for treatment of high blood pressure.

Parkinson's disease is the second most common neurodegenerative disease in the United States, second only to Alzheimer's disease. The average age of diagnosis is near 60. More than 1 million Americans currently have Parkinson's disease, and this number is rising as the population ages. The symptoms of Parkinson's disease include rigidity, slowness of movement and tremors. No treatment currently is known to prevent or slow the progression of Parkinson's disease.

Although most cases of Parkinson's disease have no known genetic link, Surmeier's study in mice showed that the mitochondrial stress in dopamine-releasing neurons was worsened in a genetic model of early-onset Parkinson's disease, suggesting a similar mechanism in rare familial forms of the disease and the more common forms.

Everyone loses dopamine-releasing neurons with age, Surmeier noted. "By lowering their metabolic stress level, we should be able to make dopamine-releasing neurons live longer and delay the onset of Parkinson's disease," he said. "For individuals diagnosed with Parkinson's disease, the hope is that this drug can slow disease progression, giving symptomatic therapies a broader window in which to work."

The study was supported by the National Institutes of Health, United States Department of Defense, Thomas Hartman Foundation For Parkinson's Research, Inc., The Picower Foundation and Dr. Ralph and Marian Falk Medical Research Trust.

Story Source:

The above story is based on materials provided by Northwestern University. The original article was written by Marla Paul. Note: Materials may be edited for content and length.

More From ScienceDaily

More Health & Medicine News

Featured Research

Mar. 2, 2015 — In the first study of its kind since the 1920s, rats in New York City were found to carry a flea species capable of transmitting plague pathogens. Among them: 500-plus Oriental rat fleas, notorious ... full story

Mar. 2, 2015 — A newly published study is the first to report an association between bisphenol-A (BPA), a common plasticizer used in a variety of consumer food and beverage containers, with autism spectrum disorder ... full story

Mar. 2, 2015 — What do a human colon, septic tank, copper nanoparticles and zebrafish have in common? They were the key components used by researchers to study the impact copper nanoparticles, which are found in ... full story

Mar. 2, 2015 — You might resemble or act more like your mother, but a novel research study reveals that mammals are genetically more like their dads. Specifically, the research shows that although we inherit equal ... full story

Mar. 2, 2015 — Scientists who have discovered the mechanism of a protein that suppresses inflammation in the body, say the information could potentially be used to develop new drugs to control inflammation. The ... full story

Mar. 2, 2015 — A deficiency in the protein responsible for moving glucose across the brain's protective blood-brain barrier appears to intensify the neurodegenerative effects of Alzheimer's disease, according to a ... full story

Mar. 2, 2015 — Researchers describe how postmortem brain slices can be 'read' to determine how a rat was trained to behave in response to specific sounds, a new article suggests. The work provides one of the first ... full story

Mar. 2, 2015 — Teenagers in North Carolina were easily able to buy electronic cigarettes online because both Internet vendors and shipping companies failed to verifying ages in a study that assessed compliance with ... full story

Mar. 2, 2015 — A survey of US high school students suggests that 1 in 5 female students and 1 in 10 male students who date have experienced some form of teen dating violence (TDV) during the past 12 months. "These ... full story

Mar. 2, 2015 — Cerebral blood flow recovery in the brain could be a biomarker of outcomes in patients following concussion, a new imaging study suggests. Most of the 3.8 million sports-related traumatic brain ... full story

GlaxoSmithKline and Novartis Try Swapping Success

Reuters - Business Video Online (Mar. 2, 2015) — GlaxoSmithKline and Novartis have completed a series of asset swaps worth more than $20 billion. As Grace Pascoe reports they say the deal will reshape both drugmakers.
Video provided by Reuters

How Can West Africa Rebuild After Ebola?

Reuters - Business Video Online (Mar. 2, 2015) — How best to rebuild the three West African countries struggling with Ebola will be discussed in Brussels this week. As Hayley Platt reports Sierra Leone has the toughest job ahead - its once thriving economy has been ravaged by the disease.
Video provided by Reuters

Related Stories

Sep. 30, 2014 — A Phase III clinical trial to evaluate the drug isradipine, a calcium channel blocker often used to treat high blood pressure, as a potential new treatment for Parkinson disease has been launched, ... full story

Oct. 24, 2012 — In an early-stage breakthrough, scientists have developed a new family of compounds that could slow the progression of Parkinson's disease. Parkinson's is the second most common ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.